1 year return (CAGR)
192.70%
UroGen Pharma Ltd Exchange (NASDAQ, USD)
URGN
41.23
-1.26 (-4.07%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
35.42%
5 year return (CAGR)
10.25%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.44B
Price/Sales
13.16
Ent value
1.64B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
25.34
EPS growth
-11.57%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 30.72 |
| Daily high | 31.21 |
| Daily low | 28.78 |
| Daily Volume | 791K |
| All-time high | 65.33 |
| 1y analyst estimate | 60.00 |
| Beta | 1.58 |
| EPS (TTM) | -1.94 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| URGN | S&P500 | |
| Current price drop from All-time high | -36.89% | -1.38% |
| Highest price drop | -93.98% | -56.47% |
| Date of highest drop | 27 May 2025 | 9 Mar 2009 |
| Avg drop from high | -61.52% | -10.68% |
| Avg time to new high | 53 days | 12 days |
| Max time to new high | 2008 days | 1805 days |
News
